Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
Sponsor: University of Alberta • ClinicalTrials.gov ID: NCT06626022
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
Interventions
-
MRI
(Device)
Standard prostate mpMRI.
-
ExactVu
(Device)
microUltrasound
Eligibility criteria
Conditions
Locations
- University of California, Los Angeles (UCLA) — Los Angeles, California, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
- University of Alberta — Edmonton, Alberta, Canada
- University of British Columbia — Vancouver, British Columbia, Canada
- Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada
- CIUSSS du Nord-de-l'Île-de-Montréal — Montréal, Quebec, Canada
- CH de Martigues — Martigues, France
- Vestfold Hospital Trust — Tønsberg, Norway
- Urologia Clinica Bilbao — Bilbao, Spain
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record